Spinal cord, brain and quadriceps muscle samples were pulverised under liquid nitrogen and the powder mixed with TRIzol reagent at a ratio of 1ml TRIzol per 100mg tissue (quadriceps muscle) or 1ml per 50mg (brain and spinal cord). Samples were extracted from tissue samples using a TRIzol protocol as supplied by the manufacturers with the addition of an extra chloroform extraction step (1:1) after collection of the aqueous phase. RNA was assessed via nanodrop to ensure good 260/280 and 260/230 ratios (>1.9). Samples with 260/230 ratios lower than 1.9 were cleaned by a second round of isopropanol precipitation.
For cDNA synthesis, 800ng of RNA per reaction was reverse transcribed using the
RTnanoscript2 kit (Primer Design) and final reactions were diluted 1/5 (empirically determined to be a sufficient dilution to prevent cDNA synthesis reagents having any effect on subsequent PCR efficiency). qPCR was performed in a
CFX384 light cycler (Biorad) using PrecisionPLUS mastermix with SYBR green (Primer Design), with 10ul volumes of primers at a final concentration of 500nM, and with 10-15ng cDNA per well. Cycling conditions: 2mins at 95°C, then 50 cycles of: 15sec 95
oC, 20sec 60°C, 20sec 72
oC followed by a melt curve (60–95
oC in 0.5 degree steps).
The following primers were used:
Pak1ip1 was used as a reference gene in all tissues (Primer Design).
Kondori N.R., Paul P., Robbins J.P., Liu K., Hildyard J.C., Wells D.J, & de Belleroche J.S. (2017). Characterisation of the pathogenic effects of the in vivo expression of an ALS-linked mutation in D-amino acid oxidase: Phenotype and loss of spinal cord motor neurons. PLoS ONE, 12(12), e0188912.